FDA Guidance for Industry: Pharmaceutical Components at Risk for Melamine Contamination
Title:
FDA Guidance for Industry: Pharmaceutical Components at Risk for Melamine Contamination
Origin/Publisher:
FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM175984.pdf
Content:
This guidance is intended to alert pharmaceutical manufacturers of finished products, pharmacy compounders, repackers, and suppliers to the potential risk of melamine contamination in pharmaceutical components.